Rationale of the Call

The EP PerMed Fast Track Validation Programme has been established to address a critical bottleneck in the development of PM solutions: the validation phase. Personalised medicine is a highly innovative and technology-driven field that holds immense potential for improving patient outcomes and optimising healthcare delivery. However, transforming groundbreaking innovations into market-ready products requires rigorous validation to ensure they meet the needs and expectations of end-users, including clinicians and patients.

Programme overview

The Fast Track Validation Programme seeks to give support to overcome these challenges by providing a structured, accelerated pathway for PM innovators to validate their solutions. By leveraging a network of validation centres, the programme offers participants the opportunity to obtain critical evidence and feedback within a condensed timeframe of six months. This expedited process helps innovators swiftly advance their projects by at least one technology readiness level (TRL) and also enhances their readiness for market entry and commercialisation.

The programme supports start-ups and small teams and researchers at a pivotal stage of development, ensuring that promising PM innovations do not stall due to lack of validation resources and guidance. Through a combination of access to top-tier validation facilities, the Fast Track Validation Programme equips innovators with the tools and knowledge necessary to bring their solutions closer to clinical use and patient benefit.

Aim of the Call

The Fast Track Validation Programme aims to accelerate the development and adoption of at least 5 innovative PM solutions in 2025, fostering advancements that can transform healthcare and improve patient outcomes. The programme contributes to the overarching goal of Personalised Medicine: delivering tailored, effective, and efficient healthcare solutions that meet the unique needs of each patient.

Eligibility criteria

For an application to proceed to evaluation, it must meet all the below eligibility criteria. Each application will be reviewed for this eligibility criteria by EP PerMed Partners.

• Applicants must submit their applications via the application platform before the deadline on 13 March 2025 at 16:00 CET.
• Applications can be submitted by either a start-up or a team/researcher affiliated with an academic or healthcare research organization registered in an EU Member State or a Horizon Europe-associated country.- If you are unsure about your eligibility, please do not hesitate to contact us using the information provided below -
• Applications must be formulated in English.

In case of interest, please click on "m'interessa" and we will contact you.